Publication:
Pneumonia after kidney transplant: Incidence, risk factors, and mortality

dc.contributor.authorDizdar, Oğuzhan Sıtkı
dc.contributor.buuauthorErsoy, Alparslan
dc.contributor.buuauthorAkalın, Halis
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıbbi Mikrobiyoloji Ana Bilim Dalı
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0000-0002-0710-0923
dc.contributor.researcheridAAH-5054-2021
dc.contributor.researcheridAAU-8952-2020
dc.contributor.scopusid35612977100
dc.contributor.scopusid57207553671
dc.date.accessioned2022-09-01T10:43:59Z
dc.date.available2022-09-01T10:43:59Z
dc.date.issued2014-06
dc.description.abstractObjectives: Pneumonia is an important cause of morbidity and mortality in recipients of solid-organ transplant. We aimed to determine risk factors for development of pneumonia and associated deaths in kidney transplant recipients. Materials and Methods: A retrospective review of medical records was performed for all kidney transplant recipients from December 1988, to April 2011. The diagnosis of community-acquired pneumonia was made from symptoms, clinical findings, and chest radiography. The diagnosis of nosocomial pneumonia was made according to published criteria. Laboratory and serologic tests, radiographic findings, cultures of respiratory specimens, and tissue biopsies were reviewed. Results: In 406 kidney transplant recipients, there were 82 patients (20%) who had 111 episodes of pneumonia, including 49 nosocomial episodes of pneumonia (44%). Bacterial infections were the most common cause (34 episodes [31%]). In multivariate analysis, significant risk factors associated with pneumonia episodes were older age, hypertension, cardiac disease, history of acute graft rejection, and not using everolimus/mycophenolate mofetil/prednisolone protocol. There were 28 episodes that resulted in death (25%), including 20 nosocomial episodes (71%). In multivariate analysis, significant risk factors associated with death from pneumonia episodes were antibiotic use in the previous 3 months, high C-reactive protein, and low albumin. Cutoff values for increased risk of death from pneumonia included C-reactive protein > 10 mg/dL and procalcitonin > 8.8 ng/mL. Conclusions: Recipients of kidney transplant may be at risk for pneumonia and associated death. Nosocomial pulmonary infections may be associated with marked morbidity and mortality in kidney transplant recipients.
dc.identifier.citationDizdar, O. S. vd. (2014). "Pneumonia after kidney transplant: Incidence, risk factors, and mortality". Experimental and Clinical Transplantation, 12(3), 205-211.
dc.identifier.endpage211
dc.identifier.issn1304-0855
dc.identifier.issue3
dc.identifier.pubmed24907720
dc.identifier.scopus2-s2.0-84901915171
dc.identifier.startpage205
dc.identifier.urihttps://doi.org/10.6002/ect.2013.0093
dc.identifier.urihttp://ectrx.org/forms/ectrxcontentshow.php?doi_id=10.6002/ect.2013.0093
dc.identifier.urihttp://hdl.handle.net/11452/28422
dc.identifier.volume12
dc.identifier.wos000337655800006
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherBaşkent Üniversitesi
dc.relation.collaborationSanayi
dc.relation.journalExperimental and Clinical Transplantation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRenal failure
dc.subjectNephrology
dc.subjectLung
dc.subjectInfection
dc.subjectCommunity-acquired pneumonia
dc.subjectPulmonary infections
dc.subjectRecipients
dc.subjectValidation
dc.subjectBacterial
dc.subjectFailure
dc.subjectTransplantation
dc.subject.emtreeAciclovir
dc.subject.emtreeAlbumin
dc.subject.emtreeAzathioprine
dc.subject.emtreeC reactive protein
dc.subject.emtreeCephalosporin
dc.subject.emtreeCotrimoxazole
dc.subject.emtreeCyclosporin
dc.subject.emtreeEverolimus
dc.subject.emtreeInterleukin 2 receptor antibody
dc.subject.emtreeIsoniazid
dc.subject.emtreeMethylprednisolone
dc.subject.emtreeMycophenolic acid 2 morpholinoethyl ester
dc.subject.emtreePrednisolone
dc.subject.emtreeRapamycin
dc.subject.emtreeTacrolimus
dc.subject.emtreeThymocyte antibody
dc.subject.emtreeValganciclovir
dc.subject.emtreeAcute graft rejection
dc.subject.emtreeAdult
dc.subject.emtreeAge
dc.subject.emtreeAntibody titer
dc.subject.emtreeArticle
dc.subject.emtreeAspergillus fumigatus
dc.subject.emtreeChronic graft rejection
dc.subject.emtreeClinical feature
dc.subject.emtreeClinical protocol
dc.subject.emtreeCommunity acquired pneumonia
dc.subject.emtreeControlled study
dc.subject.emtreeDelayed graft function
dc.subject.emtreeDiastolic blood pressure
dc.subject.emtreeDisease severity
dc.subject.emtreeDrug use
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeFemale
dc.subject.emtreeFiberoptic bronchoscopy
dc.subject.emtreeHaemophilus influenzae
dc.subject.emtreeHeart disease
dc.subject.emtreeHospital infection
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeHypertension
dc.subject.emtreeImmunosuppressive treatment
dc.subject.emtreeIncidence
dc.subject.emtreeKidney transplantation
dc.subject.emtreeLength of stay
dc.subject.emtreeLoading drug dose
dc.subject.emtreeLung lavage
dc.subject.emtreeLung mycosis
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMedical record
dc.subject.emtreeMorbidity
dc.subject.emtreeMortality
dc.subject.emtreePneumocystis pneumonia
dc.subject.emtreePseudomonas aeruginosa
dc.subject.emtreeRetrospective study
dc.subject.emtreeRisk factor
dc.subject.emtreeSensitivity and specificity
dc.subject.emtreeSingle drug dose
dc.subject.emtreeStenotrophomonas maltophilia
dc.subject.emtreeSystolic blood pressure
dc.subject.emtreeThorax radiography
dc.subject.emtreeChi square distribution
dc.subject.emtreeCommunity-acquired infections
dc.subject.emtreeComorbidity
dc.subject.emtreeCross infection
dc.subject.emtreeEpidemiology
dc.subject.emtreeGraft rejection
dc.subject.emtreeKaplan Meier method
dc.subject.emtreeKidney transplantation
dc.subject.emtreeMiddle aged
dc.subject.emtreeMortality
dc.subject.emtreeMultivariate analysis
dc.subject.emtreePneumonia
dc.subject.emtreePrognosis
dc.subject.emtreeRisk
dc.subject.emtreeStatistical model
dc.subject.emtreeTime
dc.subject.emtreeTurkey
dc.subject.emtreeYoung adult
dc.subject.meshAdult
dc.subject.meshAge factors
dc.subject.meshChi-square distribution
dc.subject.meshCommunity-acquired infections
dc.subject.meshComorbidity
dc.subject.meshCross infection
dc.subject.meshFemale
dc.subject.meshGraft rejection
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshKaplan-Meier estimate
dc.subject.meshKidney transplantation
dc.subject.meshLogistic models
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshMultivariate analysis
dc.subject.meshOdds ratio
dc.subject.meshPneumonia
dc.subject.meshPrognosis
dc.subject.meshRetrospective studies
dc.subject.meshRisk factors
dc.subject.meshTime factors
dc.subject.meshTurkey
dc.subject.meshYoung adult
dc.subject.scopusTransplant Recipients; Urinary Tract Infections; Kidney Transplantation
dc.subject.wosTransplantation
dc.titlePneumonia after kidney transplant: Incidence, risk factors, and mortality
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Tıbbi Mikrobiyoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dizdar_vd_2014.pdf
Size:
295.18 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: